Skip to content
HowShorted

Nektar Therapeutics short interest in 2026

In 2026, Nektar Therapeutics's disclosed short interest ran from 16.04% of shares outstanding on 15 Jan 2026 to 16.80% on 15 Sep 2026, a change of +0.76 percentage points. The year's high was 24.04% on 30 Jun 2026 and its low 12.66% on 15 Apr 2026, averaging 17.02% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.45 days on 31 Aug 2026. Full history: Nektar Therapeutics.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Nektar Therapeutics in 2026

2026 in figures

Start of year
16.04% (15 Jan 2026)
End of year
16.80% (15 Sep 2026)
Change
+0.76 pp
High
24.04% (30 Jun 2026)
Low
12.66% (15 Apr 2026)
Average
17.02%
Highest days to cover
11.45 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

Nektar Therapeutics short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202616.04%4.66
30 Jan 202616.16%4.63
13 Feb 202617.16%1.56
27 Feb 202616.43%3.43
13 Mar 202612.79%3.79results (8-K), 10-K filed
31 Mar 202612.77%4.34
15 Apr 202612.66%5.78
30 Apr 202614.30%2.47
15 May 202615.23%5.21results (8-K), 10-Q filed
29 May 202616.08%5.31
15 Jun 202617.23%4.93
30 Jun 202624.04%4.47
15 Jul 202623.77%6.97
31 Jul 202621.97%8.62
14 Aug 202618.07%10.43results (8-K), 10-Q filed
31 Aug 202617.77%11.45
15 Sep 202616.80%7.57

See also: Nektar Therapeutics's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.